QT Imaging Holdings, Inc.
QTIQT Imaging Holdings, Inc. is a medical technology company focused on the development and commercialization of advanced medical imaging systems.
Earnings
Next report
Aug 6, 2026 (In 3 weeks)Valuation & ratios
Competitors
By market cap
By revenue growth
By net margin
Profile
QT Imaging Holdings, Inc. is a medical technology company focused on the development and commercialization of advanced medical imaging systems. The company's core value proposition centers on its proprietary automated breast imaging technology, which utilizes transmission ultrasound to provide high-resolution images without the need for ionizing radiation or painful compression. Their primary objective is to improve the detection and monitoring of breast health through safer and more patient-friendly diagnostic tools.
An emerging player in the medical imaging space, QT Imaging differentiates itself by offering a radiation-free, non-compressive alternative to traditional breast cancer screening technologies.
Questions, answered.
- What is QT Imaging Holdings, Inc.'s market cap?
- QT Imaging Holdings, Inc. (QTI) has a market capitalization of $51.1M and trades on NASDAQ.
- What is QT Imaging Holdings, Inc.'s revenue and profitability?
- QT Imaging Holdings, Inc. generated $22.7M in trailing twelve-month revenue with a net loss of $13.4M, representing a net margin of -58.9%. Gross margin stands at 41.7%, with free cash flow of -$9.2M. These figures are based on the Q1 2026 filing.
- Who are QT Imaging Holdings, Inc.'s competitors?
- QT Imaging Holdings, Inc.'s key competitors include GE HealthCare, Lumexa Imaging Holdings, Inc. Common Stock, RadNet, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- What subsidiaries does QT Imaging Holdings, Inc. have?
- QT Imaging Holdings, Inc.'s subsidiaries include QT Imaging, Inc..
- Where is QT Imaging Holdings, Inc. headquartered?
- QT Imaging Holdings, Inc. is headquartered in United States of America and employs approximately 3 people. It has been publicly traded since 2024.
